TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

被引:0
|
作者
M. Unterrainer
D. F. Fleischmann
F. Vettermann
V. Ruf
L. Kaiser
D. Nelwan
S. Lindner
M. Brendel
V. Wenter
S. Stöcklein
J. Herms
V. M. Milenkovic
R. Rupprecht
J. C. Tonn
C. Belka
P. Bartenstein
M. Niyazi
N. L. Albert
机构
[1] University Hospital,Department of Nuclear Medicine
[2] LMU Munich,Department of Radiation Oncology
[3] German Cancer Consortium (DKTK),Department of Neuropathology
[4] Partner Site Munich,Department of Radiology
[5] and German Cancer Research Center (DKFZ),Department of Psychiatry and Psychotherapy
[6] University Hospital,Department of Neurosurgery
[7] LMU Munich,undefined
[8] LMU Munich,undefined
[9] University Hospital,undefined
[10] LMU Munich,undefined
[11] University of Regensburg,undefined
[12] University Hospital,undefined
[13] LMU Munich,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷
关键词
F-GE-180; TSPO; Glioma; Grading; Molecular genetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1368 / 1380
页数:12
相关论文
共 50 条
  • [1] TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study
    Unterrainer, M.
    Fleischmann, D. F.
    Vettermann, F.
    Ruf, V
    Kaiser, L.
    Nelwan, D.
    Lindner, S.
    Brendel, M.
    Wenter, V
    Stoecklein, S.
    Herms, J.
    Milenkovic, V. M.
    Rupprecht, R.
    Tonn, J. C.
    Belka, C.
    Bartenstein, P.
    Niyazi, M.
    Albert, N. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (06) : 1368 - 1380
  • [2] TSPO PET using 18F-GE-180: a new perspective in neurooncology?
    Langen, Karl-Josef
    Willuweit, Antje
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (13) : 2227 - 2229
  • [3] TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma
    Albert, Nathalie L.
    Unterrainer, M.
    Fleischmann, D. F.
    Lindner, S.
    Vettermann, F.
    Brunegraf, A.
    Vomacka, L.
    Brendel, M.
    Wenter, V.
    Wetzel, C.
    Rupprecht, R.
    Tonn, J. -C.
    Belka, C.
    Bartenstein, P.
    Niyazi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (13) : 2230 - 2238
  • [4] TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma
    Nathalie L. Albert
    M. Unterrainer
    D. F. Fleischmann
    S. Lindner
    F. Vettermann
    A. Brunegraf
    L. Vomacka
    M. Brendel
    V. Wenter
    C. Wetzel
    R. Rupprecht
    J.-C. Tonn
    C. Belka
    P. Bartenstein
    M. Niyazi
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2230 - 2238
  • [5] Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET
    Vettermann, Franziska J.
    Unterrainer, Marcus
    Ruf, Viktoria
    Fleischmann, Daniel F.
    Rupprecht, Rainer
    Forbrig, Robert
    Herms, Jochen
    Tonn, Joerg C.
    Belka, Claus
    Bartenstein, Peter
    Niyazi, Maximilian
    Albert, Nathalie L.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : 992 - 993
  • [6] Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study
    Marcus Unterrainer
    D. F. Fleischmann
    C. Diekmann
    L. Vomacka
    S. Lindner
    F. Vettermann
    M. Brendel
    V. Wenter
    B. Ertl-Wagner
    J. Herms
    C. Wetzel
    R. Rupprecht
    J. C. Tonn
    C. Belka
    P. Bartenstein
    M. Niyazi
    Nathalie L. Albert
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 580 - 590
  • [7] Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study
    Unterrainer, Marcus
    Fleischmann, D. F.
    Diekmann, C.
    Vomacka, L.
    Lindner, S.
    Vettermann, F.
    Brendel, M.
    Wenter, V.
    Ertl-Wagner, B.
    Herms, J.
    Wetzel, C.
    Rupprecht, R.
    Tonn, J. C.
    Belka, C.
    Bartenstein, P.
    Niyazi, M.
    Albert, Nathalie L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 580 - 590
  • [8] Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
    De Groot, Marius
    Patel, Neel
    Manavaki, Roido
    Janiczek, Robert L.
    Bergstrom, Mats
    Ostor, Andrew
    Gerlag, Danielle
    Roberts, Alexandra
    Graves, Martin J.
    Karkera, Yakshitha
    Fernando, Disala
    Mistry, Prafull
    Walker, Adam
    Wisniacki, Nicolas
    Fryer, Tim D.
    Jimenez-Royo, Pilar
    EJNMMI RESEARCH, 2019, 9 (01)
  • [9] Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
    Marius de Groot
    Neel Patel
    Roido Manavaki
    Robert L. Janiczek
    Mats Bergstrom
    Andrew Östör
    Danielle Gerlag
    Alexandra Roberts
    Martin J. Graves
    Yakshitha Karkera
    Disala Fernando
    Prafull Mistry
    Adam Walker
    Nicolas Wisniacki
    Tim D. Fryer
    Pilar Jimenez-Royo
    EJNMMI Research, 9
  • [10] TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
    Quach, Stefanie
    Holzgreve, Adrien
    Kaiser, Lena
    Unterrainer, Marcus
    Dekorsy, Franziska J.
    Nelwan, Debie, V
    Bartos, Laura M.
    Kirchleitner, Sabrina, V
    Weller, Jonathan
    Weidner, Lorraine
    Niyazi, Maximilian
    Ruf, Viktoria C.
    Herms, Jochen
    Stoecklein, Sophia
    Wetzel, Christian
    Riemenschneider, Markus J.
    Baumgarten, Louisa, V
    Thon, Niklas
    Brendel, Matthias
    Rupprecht, Rainer
    Bartenstein, Peter
    Tonn, Joerg-Christian
    Albert, Nathalie L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (03) : 859 - 869